SLCTR/2008/018已完成未知
Effect of alendronate or calcium plus vitamin D3 on thalassemic osteopathy; a randomized placebo controlled double blind clinical trial
Faculty of Medicine, University of Ruhuna0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients who are diagnosed having thalassemic osteopathy who would admit to Teaching Hospital Karapitiya for regular blood transfusion will be selected for this study
排除标准
- •1. Patient/ parents or guardian who does not give the consent. 2. Inability to comply with the visit schedule.
研究者
相似试验
已完成
不适用
Effect of alendronate and vitamin D on selected bone turnover markers in women with postmenopausal osteoporosis and a high fracture risk; a randomized controlled trialPost-menopausal osteoporosisSLCTR/2018/038
已完成
2 期
The efficacy of vitamin D and oral alendronate on Modic changeCondition 1: Lumbar discopathy. Condition 2: Spinal stenosis. Condition 3: Lumbar listesis.IRCT20140915019185N2Sari University of Medical Sciences90
已完成
不适用
Effect of Calcium -Vitamin D and Alendronate on serum Dickkopf-1( Dkk-1) and Osteoprotegerin(OPG) in women with osteoporosisosteoporosis.idiopathic osteoporosisIRCT201201238809N1Research vice chancellor of Tabriz University of Medical Sciences72
已完成
1 期
A Study of the Bioequivalence of 70 mg Alendronate and 70 mg Alendronate in Combination With 2800 IU Vitamin DOsteoporosisNCT00806416Organon and Co244
已完成
3 期
A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)Osteoporosis, PostmenopausalNCT00398606Organon and Co650